KR20160088323A - S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드 - Google Patents

S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드 Download PDF

Info

Publication number
KR20160088323A
KR20160088323A KR1020167014493A KR20167014493A KR20160088323A KR 20160088323 A KR20160088323 A KR 20160088323A KR 1020167014493 A KR1020167014493 A KR 1020167014493A KR 20167014493 A KR20167014493 A KR 20167014493A KR 20160088323 A KR20160088323 A KR 20160088323A
Authority
KR
South Korea
Prior art keywords
pro
lys
glu
ala
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020167014493A
Other languages
English (en)
Korean (ko)
Inventor
아린 가스파리안
아르만도 주니가
니나 게이브
마르코 탐보리니
마자 주드
게르드 플루쉬케
아니에브리스 말레로 노다르제
존 앤소니 로비슨
Original Assignee
비로메틱스 아게
스위스 트로피칼 앤드 퍼블릭 헬스 인스티튜트
우니베르시태트 바젤
유니베르시태트 취리히
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비로메틱스 아게, 스위스 트로피칼 앤드 퍼블릭 헬스 인스티튜트, 우니베르시태트 바젤, 유니베르시태트 취리히 filed Critical 비로메틱스 아게
Publication of KR20160088323A publication Critical patent/KR20160088323A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020167014493A 2013-12-03 2014-12-02 S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드 Ceased KR20160088323A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195402 2013-12-03
EP13195402.6 2013-12-03
PCT/EP2014/076313 WO2015082501A1 (en) 2013-12-03 2014-12-02 Proline-rich peptides protective against s. pneumoniae

Publications (1)

Publication Number Publication Date
KR20160088323A true KR20160088323A (ko) 2016-07-25

Family

ID=49765797

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167014493A Ceased KR20160088323A (ko) 2013-12-03 2014-12-02 S. 뉴모니에(S. pneumoniae)에 대항하는 보호성 프롤린-풍부한 펩티드

Country Status (12)

Country Link
US (2) US9943583B2 (enExample)
EP (1) EP3077410B1 (enExample)
JP (2) JP2017501990A (enExample)
KR (1) KR20160088323A (enExample)
CN (1) CN105793276A (enExample)
AU (1) AU2014359292B2 (enExample)
BR (1) BR112016012306A2 (enExample)
CA (1) CA2931570A1 (enExample)
HK (1) HK1225739A1 (enExample)
RU (1) RU2737638C2 (enExample)
WO (1) WO2015082501A1 (enExample)
ZA (1) ZA201603962B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210146969A (ko) * 2019-03-29 2021-12-06 고쿠리츠다이가쿠호우진 도쿄다이가쿠 폐렴 구균 표층 단백질

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10287328B2 (en) 2016-03-08 2019-05-14 KeMyth Biotech Co., Ltd. Treatment of diabetes, toll-like receptor 4 modulators and methods for using the same
US11806392B2 (en) * 2016-12-03 2023-11-07 The Uab Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
CN110891592B (zh) 2017-06-14 2024-08-13 维罗米蒂克斯股份公司 用于保护免受呼吸道合胞病毒的环状肽
CN108559784B (zh) * 2018-07-06 2021-08-20 陕西省动物研究所 一种同时检测三种病原菌的三重pcr检测用引物、探针、试剂盒及检测方法
EP3897708A1 (en) * 2018-12-20 2021-10-27 Virometix AG Lipopeptide building blocks and synthetic virus-like particles
WO2020192701A1 (en) * 2019-03-25 2020-10-01 Immunwork Inc. Composite polypeptide having a metal binding motif and molecular construct comprising the same
WO2021260176A1 (en) 2020-06-25 2021-12-30 Virometix Ag Synthetic epitopes of betacoronaviruses
US20230355737A1 (en) 2020-09-28 2023-11-09 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination
CN121693342A (zh) 2023-07-12 2026-03-17 维罗迈科斯股份公司 肺炎球菌抗原的组合物
WO2025242657A1 (en) 2024-05-21 2025-11-27 Shape Biopharmaceuticals Ag Lipopeptide building blocks and aggregates

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
GB8704647D0 (en) 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Vaccine
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5391712A (en) 1991-08-30 1995-02-21 Beckman Instruments, Inc. Non-hemolytic streptolysin O variants
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US6251405B1 (en) * 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
WO1997037026A1 (en) 1996-04-02 1997-10-09 Smithkline Beecham Corporation Novel compounds
WO1997043304A1 (en) 1996-05-14 1997-11-20 Smithkline Beecham Corporation Novel compounds
US6096863A (en) 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
CA2271720A1 (en) 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CN1285753A (zh) 1997-12-02 2001-02-28 鲍德杰克特疫苗公司 透皮给药微粒疫苗组合物
IT1320157B1 (it) 2000-01-27 2003-11-18 Combistone Italia S P A Piano e/o rivestimento per arredamento e procedimento per la suaproduzione.
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
JP2004533236A (ja) 2001-04-13 2004-11-04 ワイエス 化膿性連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｙｏｇｅｎｅｓ）の表面タンパク質
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
WO2004041157A2 (en) 2002-09-13 2004-05-21 Chiron Corporation Group b streptococcus vaccine
CA2526106A1 (en) 2003-06-26 2005-01-13 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
US8808704B2 (en) 2006-02-02 2014-08-19 The Uab Research Foundation Non-coiled protective regions of pneumococcal surface proteins PspA and PspC
PT2121732E (pt) 2006-12-09 2012-10-02 Univ Zuerich Prorektorat Forschung Feixes helicoidais de lipopéptidos de hélices enroladas e partículas sintéticas semelhantes a vírus
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210146969A (ko) * 2019-03-29 2021-12-06 고쿠리츠다이가쿠호우진 도쿄다이가쿠 폐렴 구균 표층 단백질

Also Published As

Publication number Publication date
CN105793276A (zh) 2016-07-20
JP2017501990A (ja) 2017-01-19
EP3077410A1 (en) 2016-10-12
US9943583B2 (en) 2018-04-17
AU2014359292A1 (en) 2016-06-23
RU2737638C2 (ru) 2020-12-01
ZA201603962B (en) 2020-02-26
AU2014359292B2 (en) 2019-02-28
HK1225739A1 (zh) 2017-09-15
BR112016012306A2 (pt) 2017-09-26
WO2015082501A1 (en) 2015-06-11
CA2931570A1 (en) 2015-06-11
JP2020073487A (ja) 2020-05-14
EP3077410B1 (en) 2021-02-03
US20180256698A1 (en) 2018-09-13
US20160324947A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
AU2014359292B2 (en) Proline-rich peptides protective against S. pneumoniae
US10611805B2 (en) Modified biotin-binding protein, fusion proteins thereof and applications
US8445650B2 (en) Mutant botulinum neurotoxin serotype A polypeptide and uses thereof
US12552839B2 (en) Cyclic peptides for protection against respiratory syncytial virus
CN113260377B (zh) 脂肽构建块和合成病毒样颗粒
KR20230084478A (ko) 면역원성 코로나 바이러스 융합 단백질 및 관련 방법
MXPA02009359A (es) Molecula de interes farmaceutico que contiene en su extremo n-terminal, un acido glutamico o una glutamina en la forma de una sal de adicion fisiologicamente aceptable acido fuerte.
WO2020046982A1 (en) Compositions and methods for preventing and treating virus infection
US10590178B2 (en) Chimeric vaccine against fungal infections
KR20260040241A (ko) 폐렴구균 항원의 조성물
US20230203103A1 (en) Diagnosis, prevention and treatment of coronavirus infection
Robinson et al. A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A
JP2020162607A (ja) インフルエンザウイルスワクチンおよびその使用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160531

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20191122

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210331

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210702

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210331

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I